Skip to main content
Premium Trial:

Request an Annual Quote

Exact Laboratories Is Granted Genomics Patent

Premium

M

AYNARD, Mass.--Exact Laboratories has been issued its seventh US patent, titled "Methods for the Detection of Loss of Heterozygosity," which describes methods for analyzing genetic variations, such as single-nucleotide polymorphisms for pharmacogenomics and genetics research, and enables many patient samples to be pooled for a single analysis. The company said the technology has the potential to accelerate the discovery of disease-associated genes and eventually lead to new targeted and effective pharmaceutical treatments. Exact is an applied genomics company developing proprietary, non-invasive, DNA-based screening tools for early detection of disease, especially cancer.

Filed under

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.